MIT-话题@MedSci

#MIT#

120篇内容 | 1417人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1900885, encodeId=7c58190088508, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=“新冠复阳”为何屡见不鲜？MIT惊悚研究：病毒与DNA结合了！, objectType=article, longId=205937, objectId=51bb20593ee3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51bb20593ee3, replyNumber=0, likeNumber=47, createdTime=2021-06-30, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51bb20593ee3, moduleTitle=“新冠复阳”为何屡见不鲜？MIT惊悚研究：病毒与DNA结合了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51bb20593ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900884, encodeId=e0aa1900884c5, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果, objectType=article, longId=204701, objectId=9ebf204e014c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ebf204e014c, replyNumber=0, likeNumber=31, createdTime=2021-09-27, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ebf204e014c, moduleTitle=Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ebf204e014c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900883, encodeId=76e719008837c, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=MIT“35岁以下科技创新35人”榜单揭晓，这10余位青年科学家如何颠覆生命科学领域？, objectType=article, longId=204503, objectId=6bb820450380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bb820450380, replyNumber=0, likeNumber=49, createdTime=2021-10-15, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bb820450380, moduleTitle=MIT“35岁以下科技创新35人”榜单揭晓，这10余位青年科学家如何颠覆生命科学领域？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bb820450380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900878, encodeId=f9bc19008e813, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=PKR激活剂mitapivat治疗地中海贫血：患者血红蛋白水平持续改善, objectType=article, longId=195878, objectId=aae71958e8de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aae71958e8de, replyNumber=0, likeNumber=50, createdTime=2021-05-03, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aae71958e8de, moduleTitle=PKR激活剂mitapivat治疗地中海贫血：患者血红蛋白水平持续改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aae71958e8de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900872, encodeId=184e19008e286, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=ACC 2020：MitraClip NTR和XTR设备系统对于原发性二尖瓣反流(MR)患者是安全有效（EXPAND研究）, objectType=article, longId=191562, objectId=79b419156238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79b419156238, replyNumber=0, likeNumber=33, createdTime=2020-05-04, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79b419156238, moduleTitle=ACC 2020：MitraClip NTR和XTR设备系统对于原发性二尖瓣反流(MR)患者是安全有效（EXPAND研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79b419156238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900882, encodeId=44e8190088244, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验, objectType=article, longId=203072, objectId=4a132030e2bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a132030e2bd, replyNumber=0, likeNumber=30, createdTime=2021-01-12, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a132030e2bd, moduleTitle=FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a132030e2bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900874, encodeId=4c9619008e403, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴, objectType=article, longId=192711, objectId=1064192e1193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1064192e1193, replyNumber=0, likeNumber=44, createdTime=2021-03-29, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1064192e1193, moduleTitle=Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1064192e1193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900870, encodeId=f83519008e0fd, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Mitochondrion：887名中国听力损失患者中的线粒体tRNA变异分析 , objectType=article, longId=190899, objectId=3a3a19089995, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a3a19089995, replyNumber=0, likeNumber=48, createdTime=2020-06-10, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a3a19089995, moduleTitle=Mitochondrion：887名中国听力损失患者中的线粒体tRNA变异分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a3a19089995)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900871, encodeId=f5d219008e11a, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Biorxiv: 【MIT】新肽：新冠病毒别进来！, objectType=article, longId=191188, objectId=944119118806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=944119118806, replyNumber=0, likeNumber=30, createdTime=2020-11-27, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=944119118806, moduleTitle=Biorxiv: 【MIT】新肽：新冠病毒别进来！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=944119118806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900877, encodeId=a6e719008e7e0, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=关注罕见病“地中海贫血症”：FDA授予Mitapivat孤儿药称号, objectType=article, longId=195523, objectId=770819552322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=770819552322, replyNumber=0, likeNumber=31, createdTime=2021-01-25, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=770819552322, moduleTitle=关注罕见病“地中海贫血症”：FDA授予Mitapivat孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=770819552322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900869, encodeId=74b81900869da, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=MIT利用人工智能平台发现的新型超级抗生素，可以杀死多种抗药性细菌, objectType=article, longId=188788, objectId=fc84188e88f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc84188e88f4, replyNumber=0, likeNumber=29, createdTime=2020-04-21, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc84188e88f4, moduleTitle=MIT利用人工智能平台发现的新型超级抗生素，可以杀死多种抗药性细菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc84188e88f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900879, encodeId=ca4319008e96a, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=JACC：MitraClip手术后通过医源性房间隔缺损的右向左分流, objectType=article, longId=197959, objectId=00f519e959fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f519e959fb, replyNumber=0, likeNumber=19, createdTime=2021-02-09, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f519e959fb, moduleTitle=JACC：MitraClip手术后通过医源性房间隔缺损的右向左分流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00f519e959fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900880, encodeId=a4941900880f4, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Science Translational Medicine：封面文章： MIT开发工程化微粒强化肿瘤免疫治疗, objectType=article, longId=199515, objectId=abca199515a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abca199515a3, replyNumber=0, likeNumber=29, createdTime=2021-03-10, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abca199515a3, moduleTitle=Science Translational Medicine：封面文章： MIT开发工程化微粒强化肿瘤免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abca199515a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900876, encodeId=030b19008e69c, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=MIT研究人员设计出纳米颗粒，可提高癌症免疫治疗的效果, objectType=article, longId=195371, objectId=1a121953e1a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a121953e1a7, replyNumber=0, likeNumber=36, createdTime=2020-11-30, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a121953e1a7, moduleTitle=MIT研究人员设计出纳米颗粒，可提高癌症免疫治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a121953e1a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900868, encodeId=ac8219008685f, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=MIT发布亚洲AI医疗发展情况分析报告, objectType=article, longId=184483, objectId=d76b18448392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d76b18448392, replyNumber=0, likeNumber=92, createdTime=2020-08-30, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d76b18448392, moduleTitle=MIT发布亚洲AI医疗发展情况分析报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d76b18448392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900867, encodeId=2219190086e0c, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=潘湘斌：外科理念介入方式 MitralStitch让二尖瓣反流治疗更容易, objectType=article, longId=181116, objectId=88001811169f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88001811169f, replyNumber=0, likeNumber=34, createdTime=2020-08-27, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88001811169f, moduleTitle=潘湘斌：外科理念介入方式 MitralStitch让二尖瓣反流治疗更容易, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88001811169f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900875, encodeId=e6a619008e5b9, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=一种临床试验结果分析方法—MITT, objectType=article, longId=192770, objectId=cbdf192e707b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbdf192e707b, replyNumber=0, likeNumber=29, createdTime=2020-08-16, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbdf192e707b, moduleTitle=一种临床试验结果分析方法—MITT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbdf192e707b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900873, encodeId=9d2b19008e3f8, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴, objectType=article, longId=192633, objectId=87911926336f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87911926336f, replyNumber=0, likeNumber=49, createdTime=2020-08-22, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87911926336f, moduleTitle=QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87911926336f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900863, encodeId=9f4919008638c, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=Science：MIT科学家发明两亲疫苗，大幅提高CAR-T抗癌活性，将60%小鼠肿瘤完全清除, objectType=article, longId=175724, objectId=04781e5724fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04781e5724fd, replyNumber=0, likeNumber=29, createdTime=2019-11-16, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04781e5724fd, moduleTitle=Science：MIT科学家发明两亲疫苗，大幅提高CAR-T抗癌活性，将60%小鼠肿瘤完全清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04781e5724fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1900864, encodeId=8035190086458, content=<a href='/topic/show?id=5f9b119599d' target=_blank style='color:#2F92EE;'>#MIT#</a>, objectTitle=NEJM：Mitapivat在丙酮酸激酶缺乏症中的安全性和疗效分析, objectType=article, longId=178914, objectId=3cea1e89144d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cea1e89144d, replyNumber=0, likeNumber=0, createdTime=2020-05-26, rootId=0, userName=gracezdd, userId=872f168, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cea1e89144d, moduleTitle=NEJM：Mitapivat在丙酮酸激酶缺乏症中的安全性和疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cea1e89144d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MIT

2020-05-29

gracezdd (审核中...)

前往app查看评论内容

#MIT#

“新冠复阳”为何屡见不鲜？MIT惊悚研究：病毒与DNA结合了！

2021-06-30

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Mithra宣布Donesta治疗更年期血管舒缩症状（VMS）的III期临床试验已取得积极结果

2021-09-27

gracezdd (审核中...)

前往app查看评论内容

#MIT#

MIT“35岁以下科技创新35人”榜单揭晓，这10余位青年科学家如何颠覆生命科学领域？

2021-10-15

gracezdd (审核中...)

前往app查看评论内容

#MIT#

PKR激活剂mitapivat治疗地中海贫血：患者血红蛋白水平持续改善

2021-05-03

gracezdd (审核中...)

前往app查看评论内容

#MIT#

ACC 2020：MitraClip NTR和XTR设备系统对于原发性二尖瓣反流(MR)患者是安全有效（EXPAND研究）

2020-05-04

gracezdd (审核中...)

前往app查看评论内容

#MIT#

FDA允许开展Silmitasertib治疗COVID-19患者的II期临床试验

2021-01-12

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴

2021-03-29

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Mitochondrion：887名中国听力损失患者中的线粒体tRNA变异分析

2020-06-10

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Biorxiv: 【MIT】新肽：新冠病毒别进来！

2020-11-27

gracezdd (审核中...)

前往app查看评论内容

#MIT#

关注罕见病“地中海贫血症”：FDA授予Mitapivat孤儿药称号

2021-01-25

gracezdd (审核中...)

前往app查看评论内容

#MIT#

MIT利用人工智能平台发现的新型超级抗生素，可以杀死多种抗药性细菌

2020-04-21

gracezdd (审核中...)

前往app查看评论内容

#MIT#

JACC：MitraClip手术后通过医源性房间隔缺损的右向左分流

2021-02-09

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Science Translational Medicine：封面文章： MIT开发工程化微粒强化肿瘤免疫治疗

2021-03-10

gracezdd (审核中...)

前往app查看评论内容

#MIT#

MIT研究人员设计出纳米颗粒，可提高癌症免疫治疗的效果

2020-11-30

gracezdd (审核中...)

前往app查看评论内容

#MIT#

MIT发布亚洲AI医疗发展情况分析报告

2020-08-30

gracezdd (审核中...)

前往app查看评论内容

#MIT#

潘湘斌：外科理念介入方式 MitralStitch让二尖瓣反流治疗更容易

2020-08-27

gracezdd (审核中...)

前往app查看评论内容

#MIT#

一种临床试验结果分析方法—MITT

2020-08-16

gracezdd (审核中...)

前往app查看评论内容

#MIT#

QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴

2020-08-22

gracezdd (审核中...)

前往app查看评论内容

#MIT#

Science：MIT科学家发明两亲疫苗，大幅提高CAR-T抗癌活性，将60%小鼠肿瘤完全清除

2019-11-16

gracezdd (审核中...)

前往app查看评论内容

#MIT#

NEJM：Mitapivat在丙酮酸激酶缺乏症中的安全性和疗效分析

2020-05-26

科室
- - 订阅+
  - 更多科室
工具
服务